Recerca
Àrea 1
Malalties infeccioses i SIDA
Articles de l'any 2010
Original
Originals publicats: 47
Factor d'impacte: mitjana: 4.41, total: 207.37
-
Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials
Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR, Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BYT
CLIN INFECT DIS. 2010; 50: 605-612. IF: 8.195 -
Validation of the American Thoracic Society-Infectious Diseases Society of America Guidelines for Hospital-Acquired Pneumonia in the Intensive Care Unit
Ferrer M, Liapikou A, Valencia M, Esperatti M, Theessen A, Martinez JA, Mensa J, Torres A
CLIN INFECT DIS. 2010; 50: 945-952. IF: 8.195 -
Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer
Pion M, Serramia MJ, Diaz L, Bryszewska M, Gallart T, Garcia F, Gomez R, DeLaMata FJ, Munoz-Fernandez MA
BIOMATERIALS. 2010; 31: 8749-8758. IF: 7.365 -
Nursing home-acquired pneumonia: a 10 year single-centre experience
Polverino E, Dambrava P, Cilloniz C, Balasso V, Marcos MA, Esquinas C, Mensa J, Ewig S, Torres A
THORAX. 2010; 65: 354-359. IF: 7.041 -
Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS
Guerra S, Gonzalez JM, Climent N, Reyburn H, Lopez-Fernandez LA, Najera JL, Gomez CE, Garcia F, Gatell JM, Gallart T, Esteban M
J VIROL. 2010; 84: 8141-8152. IF: 5.15
Revisió
Revisions publicades: 4
Factor d'impacte: mitjana: 1.09, total: 4.34
-
Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy
Llibre JM, Antela A, Arribas JR, Domingo P, Gatell JM, Lopez-Aldeguer J, Lozano F, Miralles C, Molto J, Moreno S, Ortega E, Riera M, Rivero A, Villalonga C, Clotet B
ENFERM INFEC MICR CL. 2010; 28: 615-620. IF: 1.393 -
Antifungal prophylaxis in oncohematologic patients: Literature review and recommendations
DeLaCamara R, Mensa J, Carreras E, Estrella MC, Rodriguez JAG, Gobernado M, Picazo J, Aguado JM, Sanz MA
MED CLIN-BARCELONA. 2010; 134: 222-233. IF: 1.231
Editorials
Editorials publicades: 1
Factor d'impacte: mitjana: 3.08, total: 3.08
-
How to promote and facilitate the early diagnosis of HIV-1 infection: the emergency department's role
Gatell JM, Zulaica D, DelRomero J, Robledo T
EMERGENCIAS. 2010; 22: 230-232. IF: 3.08
Multicèntrics
Multicèntrics publicats: 21
Factor d'impacte: mitjana: 5.66, total: 118.83
-
Triple-Class Virologic Failure in HIV-Infected Patients Undergoing Antiretroviral Therapy for Up to 10 Years
Lodwick R, Costagliola D, Reiss P, Torti C, Teira R, Dorrucci M, Ledergerber B, Mocroft A, Podzamczer D, Cozzi-Lepri A, Obel N, Masquelier B, Staszewski S, Garcia F, DeWit S, Castagna A, Antinori A, Judd A, Ghosn J, Touloumi G, Mussini C, Duval X, Ramos J, Meyer L, Warsawski J, Thorne C, Masip J, Perez-Hoyos S, Pillay D, VanSighem A, LoCaputo S, Gunthard H, Paredes R, DeLuca A, Paraskevis D, Fabre-Colin C, Kjaer J, Chene G, Lundgren JD, Phillips AN
ARCH INTERN MED. 2010; 170: 410-419. IF: 9.813 -
Modelling the Evolution and Spread of HIV Immune Escape Mutants
Fryer HR, Frater J, Duda A, Roberts MG, Phillips RE, Mclean AR
PLOS PATHOG. 2010; 6: 0-0. IF: 8.978
Guies clíniques
Guies clínique publicades: 1
Factor d'impacte: mitjana: 28.9, total: 28.9
-
Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel
Thompson MA, Aberg JA, Cahn P, Montaner JSG, Rizzardini G, Telenti A, Gatell JM, Gunthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT
JAMA-J AM MED ASSOC. 2010; 304: 321-333. IF: 28.899
Tesis
-
Influencia de los poliformismos de los genes de la inmunidad innata en el desarrollo y evolución de las infecciones tras un trasplante de órgano sólido
Doctorand: Carlos Cervera Alvarez,
Director/s: Lozano F, Moreno A -
Injertos de tejido adiposo autólogo en la lipoatrofia facial de pacientes VIH+: Comparación de dos estrategias de tratamiento y utilidad de la tomografia computerizado en la evaluación de su durabilidad.
Doctorand: Eva Guisantes Pintos,
Director/s: Martinez-Chamorro E